
The companies focus on fibrosis and oncology, and novel treatments for respiratory conditions, respectively

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.

Around 60,000 people in the US get pancreatic cancer each year, with an estimated 50,000 deaths projected annually

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year's congress revealed for pharmaceutical organisations. Together, they...

Sims previously held senior level roles at AstraZeneca, Novartis and Merck

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

The companies plan to research and develop 12 new cancer treatments

The treatment is currently being evaluated in a phase 1/2 multicentre clinical study

The acquisition builds on Gilead’s oncology pipeline, focused on addressing areas of high unmet need

The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m